In the NJDT cohort, methylation-positive tumor samples of both individual SHOX2 and RASSF1A assays showed common upregulation of folate metabolism and nucleotide metabolism and common downregulation of vasoconstriction, cell apoptosis and differentiation, and nutrition metabolism involved in tumor microenvironment. The gene discussed is SHOX2; the disease is neoplasm.